Clovis Oncology, Inc. Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Announces Retirement of Erle T. Mast as Executive Vice President & Chief Financial Officer, Effective from March 31, 2016
For the nine months, the company reported operating loss of $229.813 million against $104.569 million a year ago. Loss before income taxes was $233.828 million against $102.635 million a year ago. Net loss was $233.320 million or $6.62 per basic and diluted share against $105.124 million or $3.10 per basic and diluted share a year ago.
The company announced that Erle T. Mast, Executive Vice President & Chief Financial Officer of the company, has notified the company that he intends to retire March 31, 2016.